Since cGAS/STING signaling plays an important role in enhancing the antitumor effects of immune checkpoint inhibitors (ICI) (Jiang et al. 2020), ICIs might act synergistically in combination with CIN to elicit an antitumor immune response. The gene discussed is STING1; the disease is cervical squamous intraepithelial neoplasia.